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INFLUENCE OF TEMPERATURE IN GEL FORMATION
Figure S 4. Gel formation study at different storage temperatures: 5 ºC, 24 ºC and 35 ºC. Gel does not form at 35 ºC for being above the melting temperature, but does when cooled down again. , which also represents the change of gelling speed (cal mol -1 min -2 ). In a period of 3.3 ºC (3.3 min) 75% of the gelation occurs (t75). Various cycles of gel 1·2Br formation were performed to prove the thermoreversibility of the material. A shift of the gelling temperature is observed from the first to the second gelling cycle with no further shifts. B) Baseline-corrected DSC thermograms of the formation of gel 1·2Br alone or with different drugs (0.5 mL sample). The plot shows the influence of the type of drug on the Tonset and the t75. A B S11/S20 
INFLUENCE OF DRUG CONCENTRATION ON GEL FORMATION
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DRUG INCORPORATION STUDIES
DRUG RELEASE STUDIES
Brimonidine tartrate flux vs. Lag-time
The exact number of hours from which gel 1·brimonidine provides more brimonidine tartrate than the commercial product Mirvaso®, can be calculated by developing a system of simultaneous equations with three variables, where Eq. 1 is the equation obtained from the permeation of gel 1·brimonidine, and Eq. 2 is that from Mirvaso®, in which Ygel1 is the amount of brimonidine permeated from gel 1·brimonidine, YMirvaso is the amount permeated from Mirvaso®, and x is the time elapsed from the application in hours. Finally, Eq. 3 describes the condition that the amount permeated is the same in either case. Thus, by substituting both Eq. 1 and Eq. 2 in Eq. 3, the time at which the amount permeated is the same can be predicted. 
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1·triamcinolone vs. Positon® 
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Skin permeation parameters b J represents the permeation flux of drug through the skin (μg/h•cm 2 ). c Tlag represents the time it takes to the drug to permeate the skin completely to the receptor chamber.
d Kp is the Permeability coefficient (cm/h), and it is calculated from dividing the flux into the concentration of drug in gel [J / C0] e As is the amount of drug extracted from the skin after the experiment (µg/g·cm 2 ). 
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Mir vaso® 1·tr iamcinolone 1·betamethasone S18/S20 In-vivo efficacy pictures Figure S 12 . Picture sequence of the evolution of erythema at different times after treatment with Mirvaso®. Treatment was applied in the dorsal side of rabbit's right ear, while left ear was left without treatment as control. 
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